X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1102) 1102
humans (830) 830
male (729) 729
hypertriglyceridemia (651) 651
female (565) 565
animals (417) 417
middle aged (390) 390
adult (367) 367
triglycerides - blood (324) 324
risk factors (266) 266
triglycerides (239) 239
hypertriglyceridemia - blood (217) 217
hypertriglyceridemia - complications (216) 216
cholesterol (197) 197
insulin resistance (197) 197
aged (184) 184
rats (182) 182
mice (181) 181
hypertriglyceridemia - pathology (179) 179
atherosclerosis (174) 174
obesity (172) 172
lipids (168) 168
metabolism (167) 167
hyperlipidemia (155) 155
endocrinology & metabolism (149) 149
metabolic syndrome (147) 147
biochemistry & molecular biology (134) 134
diabetes (131) 131
insulin-resistance (131) 131
lipoproteins (130) 130
peripheral vascular disease (124) 124
abridged index medicus (114) 114
cholesterol - blood (114) 114
liver - pathology (114) 114
hypertriglyceridemia - genetics (113) 113
liver - metabolism (113) 113
research (113) 113
hypertriglyceridemia - metabolism (111) 111
hypertriglyceridemia - etiology (107) 107
insulin (107) 107
hypertriglyceridemia - drug therapy (101) 101
hypercholesterolemia (99) 99
glucose (96) 96
lipids - blood (96) 96
prevalence (96) 96
risk (96) 96
physiological aspects (92) 92
disease (90) 90
rodents (89) 89
body mass index (87) 87
nutrition & dietetics (87) 87
cardiovascular disease (86) 86
liver (86) 86
adolescent (85) 85
cardiovascular-disease (85) 85
hypertension (85) 85
pathology (85) 85
hypertriglyceridemia - epidemiology (83) 83
cholesterol, hdl - blood (81) 81
triglyceride (81) 81
dyslipidemia (80) 80
plasma (80) 80
oxidative stress (78) 78
pharmacology & pharmacy (78) 78
triglycerides - metabolism (77) 77
analysis (75) 75
disease models, animal (75) 75
lipid metabolism (75) 75
diabetes mellitus (73) 73
lipoprotein lipase (73) 73
hypertriglyceridemia - chemically induced (70) 70
diet (69) 69
medicine (69) 69
pancreatitis (69) 69
blood glucose - metabolism (68) 68
cardiac & cardiovascular systems (67) 67
health aspects (67) 67
care and treatment (65) 65
insulin - blood (65) 65
mice, inbred c57bl (65) 65
body weight (64) 64
medicine, research & experimental (64) 64
hypertriglyceridemia - diagnosis (63) 63
obesity - complications (63) 63
child (62) 62
mutation (62) 62
research article (62) 62
hematology (61) 61
inflammation (61) 61
lipoproteins - blood (61) 61
type 2 diabetes (61) 61
cholesterol, ldl - blood (60) 60
apolipoproteins (59) 59
coronary-heart-disease (59) 59
oncology (59) 59
article (58) 58
physiology (58) 58
risk-factors (58) 58
rats, wistar (57) 57
medicine, general & internal (56) 56
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1200) 1200
French (12) 12
Spanish (12) 12
Japanese (9) 9
German (5) 5
Portuguese (5) 5
Italian (2) 2
Russian (2) 2
Chinese (1) 1
Dutch (1) 1
Norwegian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Frontiers in Cellular Neuroscience, ISSN 1662-5102, 10/2018, Volume 12, pp. 380 - 380
Journal Article
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1079-5642, 04/2015, Volume 35, Issue 4, pp. 948 - 959
Objective-Activation of liver X receptor (LXR) inhibits atherosclerosis but induces hypertriglyceridemia. In vitro, it has been shown that mitogen-activated... 
atherosclerosis | foam cells | hypertriglyceridemia | lipogenesis | extracellular signal-regulated map kinases | liver X receptor | TRIGLYCERIDE | HOMEOSTASIS | PROTEIN-KINASE | CELL ACTIVATION | REVERSE CHOLESTEROL TRANSPORT | DISEASE | PERIPHERAL VASCULAR DISEASE | LIGAND | HEMATOLOGY | EXPRESSION | LIVER-X-RECEPTOR | Apolipoproteins E - deficiency | Fatty Liver - pathology | Atherosclerosis - genetics | Humans | Male | Fatty Liver - chemically induced | Orphan Nuclear Receptors - metabolism | Liver - drug effects | Fatty Liver - enzymology | Aortic Diseases - prevention & control | Foam Cells - pathology | Disease Models, Animal | Chemical and Drug Induced Liver Injury - prevention & control | Atherosclerosis - pathology | Butadienes - pharmacology | Liver - metabolism | Mitogen-Activated Protein Kinase 1 - antagonists & inhibitors | Orphan Nuclear Receptors - agonists | Fatty Liver - prevention & control | Foam Cells - enzymology | Sulfonamides - pharmacology | Mice, Knockout | Aorta - pathology | Drug Synergism | Hydrocarbons, Fluorinated - toxicity | Aortic Diseases - genetics | Mitogen-Activated Protein Kinase 3 - metabolism | Signal Transduction - drug effects | Mitogen-Activated Protein Kinase 1 - metabolism | Nitriles - pharmacology | Mitogen-Activated Protein Kinase 3 - antagonists & inhibitors | Hydrocarbons, Fluorinated - pharmacology | Hypertriglyceridemia - pathology | Foam Cells - drug effects | Atherosclerosis - enzymology | Liver X Receptors | Female | Aortic Diseases - enzymology | Chemical and Drug Induced Liver Injury - pathology | Drug Therapy, Combination | Aorta - enzymology | Chemical and Drug Induced Liver Injury - enzymology | Aortic Diseases - pathology | Aorta - drug effects | Mice, Inbred C57BL | Cholesterol - metabolism | Hep G2 Cells | Hypertriglyceridemia - enzymology | Hypertriglyceridemia - prevention & control | Hypertriglyceridemia - chemically induced | Animals | Apolipoproteins E - genetics | Sulfonamides - toxicity | Protein Kinase Inhibitors - pharmacology | Atherosclerosis - prevention & control | Index Medicus
Journal Article
Atherosclerosis, ISSN 0021-9150, 2014, Volume 233, Issue 2, pp. 419 - 428
Abstract Objectives High-fat diet (HFD) feeding in mice is characterized by accumulation of αβ T cells in adipose tissue. However, the contribution of αβ T... 
Cardiovascular | Obesity | Inflammation | T cells | Skeletal muscle | MACROPHAGES | NECROSIS-FACTOR-ALPHA | DIET-INDUCED OBESITY | INTERFERON-GAMMA | FREE FATTY-ACIDS | INSULIN-RESISTANCE | GLUCOSE | REGULATORY T-CELLS | PERIPHERAL VASCULAR DISEASE | ACCUMULATION | EXPRESSION | T-Lymphocyte Subsets - immunology | Myositis - etiology | Obesity - immunology | Receptors, Antigen, T-Cell, alpha-beta - analysis | Hypertriglyceridemia - pathology | Gene Expression Profiling | Adipose Tissue - immunology | Adoptive Transfer | Lymphopenia - pathology | Th1 Cells - immunology | Myositis - immunology | Th1 Cells - transplantation | CD4-Positive T-Lymphocytes - immunology | Myositis - prevention & control | Muscle, Skeletal - immunology | Hyperglycemia - pathology | Cell Line | Receptors, Antigen, T-Cell, alpha-beta - deficiency | Obesity - complications | Mice, Inbred C57BL | Adipose Tissue - pathology | Insulin Resistance | Interferon-gamma - physiology | Hypertriglyceridemia - metabolism | 3T3-L1 Cells | Lymphopenia - complications | Mice, Knockout | Obesity - pathology | Hyperglycemia - metabolism | Culture Media, Conditioned | Animals | Muscle Fibers, Skeletal | Hypertriglyceridemia - etiology | Hyperglycemia - etiology | Lymphopenia - immunology | Mice | Th1 Cells - secretion | Muscle, Skeletal - pathology | CD8-Positive T-Lymphocytes - immunology | Dietary Fats - toxicity | Adipose tissues | Glucose metabolism | Atherosclerosis | Muscles | Glucose | Dextrose | Index Medicus | skeletal muscle | inflammation
Journal Article
Journal Article
Lipids in Health and Disease, ISSN 1476-511X, 01/2017, Volume 16, Issue 1, pp. 1 - 15
Background: It has been demonstrated that acute oral administration of schisandrin B (Sch B), an active dibenzocyclooctadiene isolated from Schisandrae Fructus... 
Chylomicron | Hepatic steatosis | Schisandrin B | Hepatomegaly | Hypertriglyceridemia | Lipolysis | TRIGLYCERIDE | INDUCED APOPTOSIS | FATTY LIVER-DISEASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | HYPERLIPIDEMIA | RISK | OBESITY | NUTRITION & DIETETICS | STEATOSIS | INFLAMMATION | GROWTH | DYSLIPIDEMIA | Hepatomegaly - pathology | Liver - pathology | Fatty Liver - pathology | Schisandra - chemistry | Cholesterol - blood | Hypertriglyceridemia - pathology | Male | Fatty Liver - chemically induced | Apolipoprotein B-48 - blood | Lignans - adverse effects | Adipose Tissue - metabolism | Liver - drug effects | Fatty Acids, Nonesterified - blood | Antineoplastic Agents, Phytogenic - adverse effects | Fatty Liver - metabolism | Liver - metabolism | Adipose Tissue - pathology | Cell Size | Hypertriglyceridemia - metabolism | Cyclooctanes - adverse effects | Mitochondria - metabolism | Mitochondria - pathology | Cholesterol, VLDL - blood | Adipocytes - pathology | Mice, Inbred ICR | Hypertriglyceridemia - chemically induced | Animals | Hepatocyte Growth Factor - blood | Adipocytes - metabolism | Hepatomegaly - chemically induced | Triglycerides - blood | Polycyclic Compounds - adverse effects | Hepatomegaly - metabolism | Mice | Type 2 diabetes | Care and treatment | Liver diseases | Hyperlipidemia | Research | Apolipoproteins | Health aspects | Index Medicus
Journal Article
European Journal of Nutrition, ISSN 1436-6207, 4/2018, Volume 57, Issue 3, pp. 1083 - 1096
Although there is limited evidence regarding the pathophysiological effects of a high-protein diet (HD), it is believed that this type of diet could overload... 
Chemistry | Nutrition | Dietary management | Aquatic jump training | High-protein diet | Resistance training | Tissue morphology | REQUIREMENTS | BODY-WEIGHT GAIN | STRENGTH | EXERCISE | SUPPLEMENTATION | SKELETAL-MUSCLE | NUTRITION & DIETETICS | METABOLISM | APPETITE | Liver - pathology | Kidney - pathology | Rats, Wistar | Hypertriglyceridemia - pathology | Male | Hypertrophy - pathology | Muscle, Skeletal - cytology | Urea - blood | Liver - growth & development | Muscle Development | Hyperglycemia - pathology | Hyperglycemia - prevention & control | Hypertrophy - etiology | Hypertrophy - prevention & control | Blood Glucose - analysis | Muscle, Skeletal - growth & development | Diet, High-Protein - adverse effects | Kidney - growth & development | Organ Size | Kidney - cytology | Biomarkers - blood | Random Allocation | Resistance Training - adverse effects | Hypertriglyceridemia - blood | Hypertriglyceridemia - prevention & control | Animals | Hyperglycemia - blood | Hypertriglyceridemia - etiology | Triglycerides - blood | Cholesterol, HDL - blood | Creatinine - blood | Hyperglycemia - etiology | Liver - cytology | Muscle, Skeletal - pathology | Hypertrophy - blood | Proteins | Physiological aspects | Urea | Weight training | Blood cholesterol | Creatinine | Excretion | Physical training | Kidneys | Strength training | Liver | Triglycerides | Soleus muscle | Cholesterol | Protein turnover | Morphology | Rodents | Gastrocnemius muscle | High protein diet | Lipoproteins (high density) | Index Medicus
Journal Article
Brain Research, ISSN 0006-8993, 2016, Volume 1639, pp. 161 - 173
Abstract Hypertriglyceridemia (HTG) is a weak risk factor in primary ischemic stroke prevention. However, clinical studies have found a counterintuitive... 
Neurology | ApoCIII transgene | Ischemic stroke | Extreme hypertriglyceridemia | GPIHBP1 knockout, transient middle cerebral artery occlusion | GPIHBP1 knockout, transient middle | LIPOPROTEIN-BINDING PROTEIN-1 | SERUM TRIGLYCERIDE LEVEL | CAROTID ATHEROSCLEROSIS | cerebral artery occlusion | HIGH-FAT DIET | NEUROSCIENCES | INFARCT VOLUME | LIPID PROFILE | RISK-FACTOR | NONFASTING TRIGLYCERIDES | OBESITY PARADOX | APOLIPOPROTEIN-C-III | Capillary Permeability - physiology | Neurons - pathology | Humans | Hypertriglyceridemia - physiopathology | Apolipoprotein C-III - metabolism | Hypertriglyceridemia - pathology | Male | Apolipoprotein C-III - genetics | Stroke - physiopathology | Receptors, Lipoprotein - metabolism | Stroke - pathology | Brain - blood supply | Neurons - physiology | Disease Models, Animal | Severity of Illness Index | Brain - physiopathology | Brain Edema - pathology | Neuroprotection - physiology | Receptors, Lipoprotein - genetics | Mice, Transgenic | Brain Ischemia - physiopathology | Animals | Brain Edema - physiopathology | Brain Ischemia - pathology | Brain - pathology | Brain | Hyperlipidemia | Neurons | Mortality | Genes | Permeability | Apolipoproteins | Stroke (Disease) | Prevention | Analysis | Genetic research | Mice | Genetic engineering | Injuries | Protein binding | Medical research | Medicine, Experimental | Index Medicus
Journal Article
Veterinary Pathology, ISSN 0300-9858, 5/2017, Volume 54, Issue 3, pp. 484 - 489
Journal Article
European Journal of Obstetrics & Gynecology and Reproductive Biology, ISSN 0301-2115, 2011, Volume 159, Issue 1, pp. 148 - 150
Journal Article
The Journal of Nutritional Biochemistry, ISSN 0955-2863, 12/2016, Volume 38, pp. 57 - 69
Obesity emerged as the major risk factor for metabolic syndrome. Postmenopausal women are more prone to develop obesity than premenopausal women. The absence... 
Atherogenic dyslipidemia | Obesity | Soy isoflavones | Hepatic steatosis | Ovariectomy | METABOLIC SYNDROME | VISCERAL FAT | ACID | BIOCHEMISTRY & MOLECULAR BIOLOGY | LIVER-DISEASE | DECREASED ENERGY-EXPENDITURE | WOMEN | NUTRITION & DIETETICS | INSULIN-RESISTANCE | GENE-EXPRESSION | RECEPTORS | MENOPAUSAL STATUS | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Dyslipidemias - complications | Rats, Wistar | Humans | Osteoporosis, Postmenopausal - complications | Hypertriglyceridemia - pathology | Metabolic Syndrome - metabolism | Dyslipidemias - pathology | Phytoestrogens - therapeutic use | Non-alcoholic Fatty Liver Disease - complications | Diet, High-Fat | Dyslipidemias - prevention & control | Female | Soy Foods | Disease Models, Animal | Biomarkers - metabolism | Obesity - complications | Liver - metabolism | Organ Size | Hypertriglyceridemia - metabolism | Lipid Metabolism | Non-alcoholic Fatty Liver Disease - metabolism | Biomarkers - blood | Random Allocation | Metabolic Syndrome - complications | Hypertriglyceridemia - prevention & control | Animals | Hypertriglyceridemia - complications | Non-alcoholic Fatty Liver Disease - prevention & control | Dyslipidemias - metabolism | Metabolic Syndrome - prevention & control | Isoflavones - therapeutic use | Metabolic Syndrome - pathology | Dietary Supplements | Proteins | Physiological aspects | Postmenopausal women | Hypercholesterolemia | Isoflavones | Liver | Risk factors | Index Medicus
Journal Article